Tower Research Capital (TRC)’s Akso Health Group AHG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,435
Closed -$7K – 6056
2021
Q4
$7K Buy
+4,435
New +$16.4K ﹤0.01% 4885
2019
Q4
– Sell
-3,453
Closed -$16K – 3459
2019
Q3
$16K Buy
3,453
+1,541
+81% +$9.66K ﹤0.01% 2600
2019
Q2
$14K Buy
1,912
+587
+44% +$4.9K ﹤0.01% 2367
2019
Q1
$13K Buy
+1,325
New +$11.5K ﹤0.01% 2513
2018
Q4
– Sell
-14
Closed – – 3786
2018
Q3
$0 Buy
+14
New +$363 ﹤0.01% 3711
2018
Q2
– Sell
-26
Closed -$1K – 3595
2018
Q1
$1K Buy
+26
New +$861 ﹤0.01% 3041

Other funds holding AHG

Tower Research Capital (TRC)'s AHG Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of Akso Health Group (AHG) in Q1 2022, closing a stake of 4,435 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in AHG in Q1 2018 and held it in 6 quarters. The position peaked at $16K in Q3 2019. 7 funds tracked by Wall St. Rank hold AHG as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining Akso Health Group position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,435 Akso Health Group shares in Q1 2022, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in Akso Health Group in Q1 2018 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Akso Health Group position peaked at $16K in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Akso Health Group as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.